Johnson Matthey’s (JMAT) Buy Rating Reiterated at Jefferies Financial Group

Johnson Matthey (LON:JMATGet Free Report)‘s stock had its “buy” rating reissued by research analysts at Jefferies Financial Group in a report released on Tuesday, Marketbeat Ratings reports. They presently have a GBX 1,800 ($22.63) target price on the stock. Jefferies Financial Group’s target price indicates a potential upside of 33.23% from the stock’s current price.

Separately, Berenberg Bank reduced their target price on Johnson Matthey from GBX 1,650 ($20.74) to GBX 1,500 ($18.86) and set a “hold” rating on the stock in a report on Thursday, November 28th.

Get Our Latest Stock Analysis on JMAT

Johnson Matthey Trading Down 2.0 %

LON JMAT opened at GBX 1,351 ($16.99) on Tuesday. The firm has a market capitalization of £2.35 billion, a PE ratio of 2,329.31, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The business’s 50-day moving average price is GBX 1,474.99 and its two-hundred day moving average price is GBX 1,573.18. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 63.15. Johnson Matthey has a 12 month low of GBX 1,318 ($16.57) and a 12 month high of GBX 1,917.07 ($24.10).

Insiders Place Their Bets

In other news, insider Stephen Oxley bought 24 shares of Johnson Matthey stock in a transaction dated Wednesday, November 20th. The stock was bought at an average cost of GBX 1,504 ($18.91) per share, for a total transaction of £360.96 ($453.81). Also, insider Liam Condon purchased 27 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were purchased at an average cost of GBX 1,505 ($18.92) per share, for a total transaction of £406.35 ($510.88). Over the last three months, insiders acquired 7,458 shares of company stock worth $10,024,332. 0.61% of the stock is owned by corporate insiders.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Stories

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.